About Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by a group of operating and investment professionals with deep software domain expertise and a proven track record of building software platforms through strategic acquisitions and organic growth. In 2016, Anju acquired Online Business Applications (OBA), the market leader in medical information solutions for the pharmaceutical and CRO industries. The OBA transaction was followed by the acquisitions of OpenQ (Key Opinion Leader management) and ClinPlus (eClinical solutions).
For more information, please visit the Anju Software website.
Sylogent delivers software and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market. The company is uniquely positioned to operate within core business units, and across the enterprise, to ensure timely completion of critical information, maximize compliance goals and reduce risk management liability. For more information on Sylogent, please visit www.sylogent.com.
About Providence Equity
Providence is a premier global private equity firm with more than $54 billion in capital under management. Providence pioneered a sector-focused approach to private equity investing with the vision that a dedicated team of industry experts could build exceptional companies of enduring value. Since the firm's inception in 1989, Providence has invested in more than 160 companies and is the leading equity investment firm focused on the media, communications, education and information industries. Providence is headquartered in Providence, RI, and also has offices in New York and London. For more information, please visit www.provequity.com.
Madison Park Group is pleased to announce that its client, Anju Software, a life sciences software platform backed by Providence Equity, has acquired the assets of Sylogent, a leading provider of business automation, publishing planning and clinical disclosure & compliance solutions to the pharma, medical device and biotech industries. This marks Anju's fourth acquisition in the life sciences software sector.
Kurien Jacob, CEO of Anju Software, commented:
“Sylogent has state-of-the-art cloud-based software solutions that enhance current Anju solutions in the Medical Affairs and Clinical Trials space."
Madison Park Group has been Anju Software’s M&A advisor since inception and has a deeply integrated partnership with Anju to strategically formulate and implement its acquisition strategy. With an integrated platform, Anju Software currently offers a comprehensive set of solutions including medical information management, KOL management & compliance, electronic data capture (EDC), clinical trial management system (CTMS) and coding. The acquisition of Sylogent provides Anju a marquee customer base and further bolsters Anju’s eClinical and medical affairs focused offering by adding clinical disclosure, publishing planning and information lifecycle management capabilities.
MPG’s Rohan Khanna commented on the transaction:
"Anju is now a dominant player in the eClinical and medical affairs landscape. With a market-leading customer proposition, Anju has actionable plans to further accelerate growth and product offerings both organically and inorganically.”